Unleashing Unpredictability: The Batman Project and Its Impact on Prosocial Behavior and Awareness
Launched by CATHOLIC UNIVERSITY OF THE SACRED HEART · Jun 27, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "The Batman Project," is studying how an unexpected event, like someone dressed as Batman, can influence people's kindness and helpfulness towards others in a public setting, specifically on the Milan metro. The researchers want to see if the presence of the Batman character affects how passengers respond to a student who will pretend to be pregnant while sitting quietly and looking at her phone. The study will compare situations where Batman is present to those where he is not, to understand if this unusual sight encourages people to be more supportive and caring.
To participate in this trial, you need to be a passenger on the metro, but the study won't take place if the train is too crowded or if there are seats available. If you're eligible and take part, you can expect to go about your usual routine while researchers observe how people react in these different scenarios. This study aims to explore the impact of unexpected events on social behavior, which could help us understand how to promote kindness in our communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being a passenger in the metro
- Exclusion Criteria:
- • Metro too crowded
- • Seats available
About Catholic University Of The Sacred Heart
The Catholic University of the Sacred Heart is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a strong emphasis on ethical standards and community well-being, the university actively engages in clinical trials that contribute to innovative healthcare solutions. Its multidisciplinary approach leverages expertise from various fields, fostering collaborations that enhance the quality and impact of research. The university is dedicated to improving patient outcomes through rigorous science and compassionate care, aligning with its mission to serve the greater good.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported